Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial (Q42981494)
Jump to navigation
Jump to search
scientific article published on 18 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial |
scientific article published on 18 June 2012 |
Statements
1 reference
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial (English)
1 reference
Stanislas Pol
1 reference
Reem H Ghalib
1 reference
Vinod K Rustgi
1 reference
Claudia Martorell
1 reference
Greg T Everson
1 reference
Harvey A Tatum
1 reference
Christophe Hézode
1 reference
Joseph K Lim
1 reference
Jean-Pierre Bronowicki
1 reference
Gary A Abrams
1 reference
Norbert Bräu
1 reference
David W Morris
1 reference
Paul J Thuluvath
1 reference
Robert W Reindollar
1 reference
Philip D Yin
1 reference
Ulysses Diva
1 reference
Robert Hindes
1 reference
Fiona McPhee
1 reference
Dennis Hernandez
1 reference
Megan Wind-Rotolo
1 reference
Eric A Hughes
1 reference
Steven Schnittman
1 reference
18 June 2012
1 reference
1 reference
12
1 reference
9
1 reference
671-677
1 reference
Identifiers
1 reference
1 reference